SCHEMBL6183281

SCHEMBL6183281

CCOC(=O)c1cc(F)c(N2CC(N[C@@H](C)c3ccccc3)C3(CC3)C2)c(OC)c1F

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.36
TP53 P04637 1/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 5/20 0.36
P2RY12 Q9H244 2/20 0.36
POLB P06746 1/20 0.36
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
PPP1CA P62136 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
MAPT P10636 3/20 0.33
MEN1 O00255 1/20 0.33
GAA P10253 1/20 0.33
KMT2A Q03164 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
TOP1 P11387 1/20 0.33
USP19 O94966 1/20 0.33
NPY2R P49146 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6183285 1.00 LMNA (0.36) LMNATP53ALDH1A1KDM4EP2RY12
SCHEMBL6184777 0.90 TOP1 (0.34) LMNAALDH1A1KDM4EPOLBNPSR1
SCHEMBL6184781 0.90 TOP1 (0.34) LMNAALDH1A1KDM4EPOLBNPSR1
SCHEMBL6183624 0.79 DRD2 (0.35) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6183620 0.79 DRD2 (0.35) ALDH1A1KDM4EMAPTMEN1KMT2A
SCHEMBL6184183 0.74 ALDH1A1 (0.35) LMNAALDH1A1KDM4EMAPTMEN1
SCHEMBL6184376 0.71 KDM4E (0.33) LMNAALDH1A1KDM4EMAPTMEN1
SCHEMBL6184374 0.71 KDM4E (0.33) LMNAALDH1A1KDM4EMAPTMEN1
SCHEMBL6181606 0.69 KCNH2 (0.33) LMNAALDH1A1KDM4EPOLBALOX15
SCHEMBL6181610 0.69 KCNH2 (0.33) LMNAALDH1A1KDM4EPOLBALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143407-A1 Process for porducing quinolonecarboxylic acid derivative DAIICHI PHARMACEUTICAL CO., LTD (JP) 2005-06-30 US disclosed
EP-1518856-A1 PROCESS FOR PRODUCING QUINOLONECARBOXYLIC ACID DERIVATIVE DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-03-30 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143407-A1 Process for porducing quinolonecarboxylic acid derivative PORCN, POR, COASY LMNA 1492/4885TP53 4173/4885ALDH1A1 2180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.